Skip to content

PHARMAELA

Active Private limited companyfounded 2023active for 3 yearsRue Paul Pastur 320, 7390 QuaregnonKBO/BCE: BE 0802.941.155

Lifetime

2 annual accounts with figures on one time axis
peak of €121,940 in 2024
€51,469▼ 57.8%
lowest -€30,599 in 2025
-€30,599▼ €32,387
peak of €11,788 in 2024
-€18,810▼ €30,599
€304,924▲ 9.5%
Board1 name since 2023
1 director
Documentsfilings and deeds
05-07-202626 days before the deadline
2025micro format
Gross margin from €121,940 to €51,469Loss of €30,599Equity from €11,788 to -€18,810Cash from €13,472 to €8,836

Key points

from the 2025 annual accounts

Equity

-€18,810
20242025

Debts exceed assets in financial year 2025.

Turnover

≈ €250,000 estimated

The micro format states no turnover.

Debts

€304,924 107% of the balance sheet
Financial debts 16%Suppliers 56%Taxes and wages 4%Other 24%

Of this, €227,028 falls due within a year.

Staff

1 employees on 31-12-2025
202024012025

In 2025, nobody joined and 1 employee left.

Position in the sector

-€30,599

Lower net result than 92% of companies in retail trade. Sector median €4,755 · 25,291 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 7,655 companies had the same profile as PHARMAELA has now. Each dot stands for 20 companies, two years later.

84.6%
were still trading
5.8%
stopped another way
8.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 0.7% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,655 companies, not a prediction for PHARMAELA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 20-06-2023
  • founderdeed of 22-06-2023
  • founderdeed of 22-06-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0802941155
Incorporation Founding capital of €10,000 · Founded by and · appointed as director · published on 22-06-2023 · Gazette deed
First establishment Rue Paul Pastur 320, Quaregnon
All 5 events

Comparable companies

same main activity, similar in size and age
Company
PHARMAELA Quaregnon €286,114 €51,469 -6.6% -
MaPharma Charleroi €256,730 €45,535 -40.9% -
LMEDICATION Fleurus €228,494 €57,349 19.7% -
ELAPHARMA Brussels €236,353 €54,058 72.1% -
PHARMACIE MOLINVAUX Liège €349,144 €69,529 20.1% -
PHARMACIE V. PIROTTE Seraing €209,269 €60,759 7.9% -
PHARMACIE BESONRIEUX CENTRE La Louvière €377,209 €81,334 2.1% 1.2

These companies have the same main activity as PHARMAELA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €209,000 and €377,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 20-06-2023Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 2 others
Establishment unit
2.346.870.7557390 Quaregnon, since 20-06-2023
Financial year end
31 December
Peppol
Reachable since 03-02-2026
Company details

Annual accounts 2025

€286,114▼ 1.4%
Employeeson 31-12-2025
1▼ 50.0%
Filing
Filed on 05-07-2026, 26 days before the end of the filing period
Financials

Insights on PHARMAELA

The 2025 annual accounts show negative equity of -€18,810 and a net result of -€30,599. Its solvency ranks better than 20% of 25,320 sector peers (NACE 47) in financial year 2025.

The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMAELA

What is the company number of PHARMAELA?
The company number of PHARMAELA is 0802.941.155. The VAT number is the same number with BE in front: BE 0802.941.155.
Where is PHARMAELA based?
The registered office is at Rue Paul Pastur 320, 7390 Quaregnon.Company details
What does PHARMAELA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMAELA?
PHARMAELA is a private limited company (BV).
When was PHARMAELA founded?
PHARMAELA was founded on 20-06-2023.
Is PHARMAELA still active?
Yes, PHARMAELA is an active enterprise in the KBO register.
How many employees does PHARMAELA have?
PHARMAELA had an average of 1.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMAELA?
The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €51,469 and 54 comparable companies (NACE 477). It probably lies between €130,000 and €360,000.
Is PHARMAELA profitable?
In financial year 2025, PHARMAELA made a loss of €30,599.
Where can I find the annual accounts of PHARMAELA?
PHARMAELA filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMAELA due?
PHARMAELA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.